TP508 ACUTE THERAPY FOR PATIENTS WITH RESPIRATORY VIRUS INFECTION

摘要

Certain embodiments are directed to using TP508 as a drug that can restore prevent alveolar damage, reducing pulmonary edema and prevent respiratory failure and mortality-associated progression of COVID-19.